Hyundai Bioscience Co (XKRX:048410) Total Stockholders Equity : ₩46,411 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Total Stockholders Equity?

Hyundai Bioscience Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩46,411 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hyundai Bioscience Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩1,165.87. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hyundai Bioscience Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.12.

Hyundai Bioscience Co Total Stockholders Equity Historical Data

The historical data trend for Hyundai Bioscience Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Total Stockholders Equity Chart

Hyundai Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

47,757.73

52,337.62

61,570.77

58,235.39

45,271.01

Hyundai Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															57,018.79	55,212.00	53,368.58	45,271.01	46,410.84

Hyundai Bioscience Co (XKRX:048410) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hyundai Bioscience Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(46410.841	-	0)	/	39.8078
	=	1,165.87

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hyundai Bioscience Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5509.538	+	24.159)	/	46410.841
	=	0.12

Hyundai Bioscience Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Bioscience Co (XKRX:048410) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR

Website

http://www.hyundaibioscience.com

Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines